Duodopa® treatment for advanced Parkinson's disease: A review of efficacy and safety
- 30 September 2012
- journal article
- review article
- Published by Elsevier BV in Parkinsonism & Related Disorders
- Vol. 18 (8), 916-929
- https://doi.org/10.1016/j.parkreldis.2012.06.022
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Malnutritional neuropathy under intestinal levodopa infusionJournal of Neural Transmission, 2011
- Jejunal levodopa infusion in long‐term DBS patients with Parkinson's diseaseMovement Disorders, 2011
- Long-term exposure to duodenal levodopa/carbidopa infusion therapy improves quality of life in relation especially to mobility, activities of daily living, and emotional well-beingActa Neurologica Scandinavica, 2011
- Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's diseaseMovement Disorders, 2011
- Gender differences in Parkinson's disease: Clinical characteristics and cognitionMovement Disorders, 2010
- Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's diseaseMovement Disorders, 2009
- Long-term experience with continuous duodenal levodopa–carbidopa infusion (Duodopa): report of six patientsNeurological Sciences, 2009
- Enteral Levodopa/Carbidopa Infusion in Advanced Parkinson DiseaseClinical Neuropharmacology, 2008
- Gender differences in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2007
- The development and validation of a short measure of functioning and well being for individuals with Parkinson's diseaseQuality of Life Research, 1995